The effect of mammalian target of rapamycin versus calcineurin inhibitor-based immunosuppression on measured versus estimated glomerular filtration rate after orthotopic liver transplantation

Transplantation

Volumn 99, Issue 6, 2015, Pages 1250-1256

  Zitta, Sabine ^a   Schaffellner, Silvia ^a   Gutschi, Jürgen ^a   Meinitzer, Andreas ^a   Kniepeiss, Daniela ^a   Artinger, Katharina ^a   Reibnegger, Gilbert ^a   Rosenkranz, Alexander R ^a   Wagner, Doris ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN INHIBITOR; CREATININE; CYSTATIN C; MAMMALIAN TARGET OF RAPAMYCIN; IMMUNOSUPPRESSIVE AGENT; INULIN; MTOR PROTEIN, HUMAN; TARGET OF RAPAMYCIN KINASE;

ADULT; AGED; ARTICLE; CHRONIC KIDNEY DISEASE; CLINICAL EFFECTIVENESS; CREATININE BLOOD LEVEL; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; IMMUNOMODULATION; INTERMETHOD COMPARISON; INULIN CLEARANCE; KIDNEY FAILURE; KIDNEY FUNCTION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TREATMENT INDICATION; ADVERSE EFFECTS; ANTAGONISTS AND INHIBITORS; COMPARATIVE STUDY; DIAGNOSTIC USE; DRUG EFFECTS; EVALUATION STUDY; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY; KIDNEY FUNCTION TEST; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; PROSPECTIVE STUDY; RENAL INSUFFICIENCY, CHRONIC; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CALCINEURIN INHIBITORS; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; INULIN; KIDNEY; KIDNEY FUNCTION TESTS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RENAL INSUFFICIENCY, CHRONIC; TOR SERINE-THREONINE KINASES;

EID: 84930543059     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0000000000000521     Document Type: Article

References (36)

1. Merion RM. Current status and future in liver transplantation. Semin Liver Dis 2010;30:411.
2. Mells G, Neuberger J. Long term care of the liver allograft recipient. Semin Liver Dis 2009;29:102.
3. Ojo AO, Held PJ, Port FK. Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med 2003;349:931-940.
4. Lynn M, Abero K, Zibari G. End stage renal disease in liver transplants. Clin Transpl 2001;15(Suppl 6): 66.
5. Pawarode A, Fine DM, Thuluvath PO. Independent risk factors and natural history of renal dysfunction in liver transplant recipients. Liver Transpl 2003;9:741.
6. Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009;150:604.
7. National Kidney Foundation. Kidney disease outcomes quality initiative. Clinical practice guidelines for chronic kidney disease: evaluation classification and stratification. Am J Kidney Dis 2002;39:S1.
8. Levey AS, Coresh J, Greene T, et al., Chronic Kidney Disease Epidemiology Collaboration. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 2006;145:247.
9. Miller WG. Reporting estimated GFR: A laboratory perspective [Editorial]. Am J Kidney Dis 2008;52:645.
10. Ekonyan G. Chronic kidney disease and classification: the quest for refinements. Kidney Int 2007;72:1183.
11. Wetzels JF, Kiemeney LA, Swinkels DW. Age and gender-specific reference values of estimated GFR in Caucasians: the Nujmegen Biomedical Study. Kidney Int 2007;72:632.
12. Zitta S, SchrabmairW, Reibnegger G, et al. Glomerular filtration rate(GFR) determination via individual kinetics of the Inulin-like polyfructosan sinistrin versus creatinine-based population-derived regression formulae. BMC Nephrol 2013;14:159.
13. Stevens LA, Schmid CH, Greene T, et al. Comparative performance of the CKD Epidemiology Collaboration(CKD-EPI) and the Modification of Diet in Renal Disease(MDRD) Study equations for estimating GFR levels above 60 mL/min/1, 73 m2. Am J Kidney Dis 2010;56:486.
14. Delanaye P, Cavalier E, Mariat C, et al. MDRD or CKD-EPI study equations for estimating prevalence of stage 3 CKD in epidemiological studies: which difference Is this difference relevant? BMC Nephrol 2010;11:8.
15. Boudville N, Salama M, Jeffrey JP, Ferrari P. The inaccuracy of cystatin C and creatinine-based equations in predicting GFR in orthotopic liver transplant recipients. Nephrol Dial Transplant 2009;24:2926.
16. Wagner D, Kniepeiss D, Stiegler P, et al. The assessment of GFR after orthotopic liver transplantation using cystatin C and creatinine based equations. Transpl Int 2012;25:527.
17. Zbroch E, Malyszko J, Mysliwiec M, et al. Hypertension in solid organ transplant recipients. Ann Transplant 2012;17:100.
18. Umbro I, Tinti F, Piselli P, et al. Occurrence of chronic renal failure in liver transplantation: monitoring of pre and posttransplant renal function. Transplant Proc 2012;44:1956.
19. Fischer L, Klempnauer J, Beckebaum S, et al. A randomized controlled study to assess the conversion from CNI to everolimus after liver transplantation-PROTECT. Am J Transplant 2012;12:1855.
20. Durand F. Hot topic debate on kidney function: renal sparing approaches are beneficial. Liver Transpl 2011;17:S43.
21. De Simone P, Neves F, De Carlis L, et al., H2304 Study Group. Everolimus with reduced tacrolimus improves renal function in de novo liver transplant recipients: A randomized, controlled trial. Am J Transplant 2012;12:3008.
22. Sharma P, Welch K, Eikstadt R, et al. Renal outcomes after liver transplantation in the model for end stage liver disease era. Liver Transpl 2009;15:1142.
23. Gonwa TA, McBride MA, Anderson K, et al. Continued influence of preoperative renal function on outcome of orthotopic liver transplant [OLTX] in the US: where will MELD lead us? Am J Transplant 2006;6:2651.
24. Shaffi K, Uhlig K, Perrone RD, et al. Performance of creatinine-based GFR estimating equations in solid-organ transplant recipients. Am J Kidney Dis 2014; 63:1007.
25. Boudjema K, Camus C, Saliba F, et al. Reduced dose tacrolimus with mycophenolate mofetil vs. standard-dose tacrolimus in liver transplantation. A randomized study. Am J Transplant 2011;11:965.
26. Calmus Y, Conti F, Cluzel P, et al. Prospective assessment of renal histopathological lesions in patients with end-stage liver disease: effects on long-term renal function after liver transplantation. J Hepatol 2012;57:572.
27. Kubal C, Cockwell P, Gunson B, et al. Chronic kidney disease after nonrenal solid organ transplantation: A histological assessment and utility of chronic allograft damage index scoring. Transplantation 2012;93:406.
28. Wagner D, Zitta S, Rosenkranz AR. Estimating glomerular filtration rate. N Engl J Med 2012;367:1262.
29. Lehner F, Gottlieb J, Bara C, et al. Biopsy-diagnosed renal disease in patients after transplantation of other organs and tissues. Am J Transplant 2010;10:2017.
30. Mariat C, Alamartine E, Barthelemy JC, et al. Assessing renal graft function in clinical trials: can tests predicting glomerular filtration rate substitute for a reference method? Kidney Int 2004;65:289.
31. Maillard N, Alamartine E, Berthoux F, et al. On the demanding necessity of properly evaluating renal graft function in clinical trials. Transpl Int 2009;22:247.
32. Zitta S, Stoschitzky K, Zweiker R, et al. Dynamic renal function testing by compartmental analysis: Assessment of renal functional reserve in essential hypertension. Nephrol Dial Transplant 2000;15:1162.
33. Kniepeiss D, Iberer F, Grasser B, et al. A single center experience with retrograde reperfusion in liver transplantation. Transpl Int 2003;16:730.
34. Finney H, Newman DJ, Gruber W. Initial evaluation of Cystatin C measurement by particle-enhanced immunonephelometry on the Behring nephelometer systems [BNA, BN II]. Clin Chem 1997;43:1016.
35. KDOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification. Part 4. Definition and classification of stages of chronic kidney disease. Am J Kidney Diseases. 2002;39(Suppl 1).
36. Chen Y-W, Chang C-W, Chang C-W, et al. Is an estimated glomerular filtration rate better than creatinine to be incorporated into the end-stage liver disease score? World J Hepatol 2012;4:291.